Frequently, medicinal development has focused on small agents, but amino acid alliances are rapidly gaining attention. This new methodology embraces combining peptides with other medicinal methods to confront challenging disease pathways. By utilizing the specific features of peptides – such as high specificity and bioavailability – researchers